Skip to content
10-Q

Quarterly Report

GINKGO BIOWORKS HOLDINGS, INC. DNA DNABW

0001628280-25-038982

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 54.86M sh
Shares Diluted Q2 2025 · Jun 30, 2025 54.55M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 51.38M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 50.75M sh
Shares Outstanding Q2 2025 · Jun 30, 2025 55.43M sh
Shares Outstanding Q2 2025 · Dec 31, 2024 54.37M sh
Capex Q2 2025 · Jun 30, 2025 $7.66M
Capex Q2 2025 · Jun 30, 2024 $33.74M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$91.78M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$173.65M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $203.57M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $561.57M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $730.37M
Cash And Equivalents Q2 2025 · Dec 31, 2023 $944.07M
Current Liabilities Q2 2025 · Jun 30, 2025 $96.72M
Current Liabilities Q2 2025 · Dec 31, 2024 $107.27M
Total Liabilities Q2 2025 · Jun 30, 2025 $618.06M
Total Liabilities Q2 2025 · Dec 31, 2024 $661.39M
Current Assets Q2 2025 · Jun 30, 2025 $523.03M
Current Assets Q2 2025 · Dec 31, 2024 $602.74M
Total Assets Q2 2025 · Jun 30, 2025 $1.23B
Total Assets Q2 2025 · Dec 31, 2024 $1.38B
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.10
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.77
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$4.23
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$7.56
Eps Basic Q2 2025 · Jun 30, 2025 −$1.10
Eps Basic Q2 2025 · Jun 30, 2025 −$2.77
Eps Basic restated Q2 2025 · Jun 30, 2024 −$4.23
Eps Basic restated Q2 2025 · Jun 30, 2024 −$7.55
Sga Expense Q2 2025 · Jun 30, 2025 $43.28M
Sga Expense Q2 2025 · Jun 30, 2025 $92.32M
Sga Expense Q2 2025 · Jun 30, 2024 $66.29M
Sga Expense Q2 2025 · Jun 30, 2024 $136.57M
Rd Expense Q2 2025 · Jun 30, 2025 $53.37M
Rd Expense Q2 2025 · Jun 30, 2025 $124.29M
Rd Expense Q2 2025 · Jun 30, 2024 $134.22M
Rd Expense Q2 2025 · Jun 30, 2024 $270.68M
Operating Income Q2 2025 · Jun 30, 2025 −$65.54M
Operating Income Q2 2025 · Jun 30, 2025 −$154.51M
Operating Income Q2 2025 · Jun 30, 2024 −$222.95M
Operating Income Q2 2025 · Jun 30, 2024 −$400.95M
Revenue Q2 2025 · Jun 30, 2025 $49.6M
Revenue Q2 2025 · Jun 30, 2025 $97.92M
Revenue Q2 2025 · Jun 30, 2024 $56.21M
Revenue Q2 2025 · Jun 30, 2024 $94.15M